Virtu KCG Holdings’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$106K	Sell	38,515 -55,320	-59%	-$155K	﹤0.01%	2399
2017 Q1	$283K	Buy	93,835 +78,390	+508%	+$223K	0.01%	2016
2016 Q4	$49K	Buy	15,445 +1,751	+13%	+$5.38K	﹤0.01%	3090
2016 Q3	$47K	Sell	13,694 -44,652	-77%	-$123K	﹤0.01%	2791
2016 Q2	$133K	Buy	+58,346	New	+$143K	﹤0.01%	2472
2016 Q1	–	Sell	-44,509	Closed	-$147K	–	3278
2015 Q4	$147K	Buy	44,509 +26,994	+154%	+$80.7K	0.01%	2866
2015 Q3	$42K	Sell	17,515 -97,779	-85%	-$253K	﹤0.01%	3031
2015 Q2	$338K	Buy	115,294 +99,324	+622%	+$385K	0.01%	1921
2015 Q1	$64K	Buy	+15,970	New	+$55.3K	﹤0.01%	2769
2014 Q4	–	Sell	-86,618	Closed	-$220K	–	4018
2014 Q3	$220K	Buy	86,618 +27,651	+47%	+$66.6K	0.01%	2792
2014 Q2	$145K	Buy	+58,967	New	+$133K	0.01%	3179
2014 Q1	–	Sell	-87,700	Closed	-$255K	–	3835
2013 Q4	$255K	Buy	+87,700	New	+$265K	0.01%	2821